Challenges on Multiple Endpoints in Clinical Trials: An Industry Survey in Japan

被引：0
作者：
Kentaro Sakamaki
Seitaro Yoshida
Yusuke Morita
Toshifumi Kamiura
Katsuhiro Iba
Naoyuki Ogawa
Hideki Suganami
Satoru Tsuchiya
Satoru Fukimbara
机构：
[1] The University of Tokyo,Department of Biostatistics and Bioinformatics
[2] Yokohama City University,Center for Data Science
[3] Japan Pharmaceutical Manufacturers Association,Data Science Expert Committee, Drug Evaluation Committee
[4] Chugai Pharmaceutical Co,Clinical Information & Intelligence Department
[5] Ltd,Clinical Data Science and Affairs
[6] Kyorin Pharmaceutical Co,Data Science Department
[7] Ltd,Department of Biometrics
[8] Nippon Shinyaku Co,Clinical Development Department
[9] Ltd,Clinical Data Science Department
[10] Otsuka Pharmaceutical Co,Data Science
[11] Ltd,Data Science
[12] Sanwa Kagaku Kenkyusho Co,undefined
[13] Ltd,undefined
[14] Kowa Company,undefined
[15] Ltd,undefined
[16] Sumitomo Dainippon Pharma Co,undefined
[17] Ltd,undefined
[18] Ono Pharmaceutical Co,undefined
[19] Ltd,undefined
来源：
Therapeutic Innovation & Regulatory Science | 2020年 / 54卷
关键词：
multiple endpoints; terminology; determination of endpoint; multiplicity adjustment; industry survey;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：528 / 533
页数：5
相关论文
共 37 条
  • [1] Challenges on Multiple Endpoints in Clinical Trials: An Industry Survey in Japan
    Sakamaki, Kentaro
    Yoshida, Seitaro
    Morita, Yusuke
    Kamiura, Toshifumi
    Iba, Katsuhiro
    Ogawa, Naoyuki
    Suganami, Hideki
    Tsuchiya, Satoru
    Fukimbara, Satoru
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2020, 54 (03) : 528 - 533
  • [2] Multiplicity Adjustment and Sample Size Calculation in Clinical Trials with Multiple Endpoints: An Industry Survey of Current Practices in Japan
    Kentaro Sakamaki
    Yusuke Morita
    Katsuhiro Iba
    Toshifumi Kamiura
    Seitaro Yoshida
    Naoyuki Ogawa
    Hideki Suganami
    Satoru Tsuchiya
    Satoru Fukimbara
    Therapeutic Innovation & Regulatory Science, 2020, 54 : 1097 - 1105
  • [3] Multiplicity Adjustment and Sample Size Calculation in Clinical Trials with Multiple Endpoints: An Industry Survey of Current Practices in Japan
    Sakamaki, Kentaro
    Morita, Yusuke
    Iba, Katsuhiro
    Kamiura, Toshifumi
    Yoshida, Seitaro
    Ogawa, Naoyuki
    Suganami, Hideki
    Tsuchiya, Satoru
    Fukimbara, Satoru
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2020, 54 (05) : 1097 - 1105
  • [4] Implementing optimal allocation in clinical trials with multiple endpoints
    Wang, Lu
    Chen, Yong
    Zhu, Hongjian
    JOURNAL OF STATISTICAL PLANNING AND INFERENCE, 2017, 182 : 88 - 99
  • [5] Inference on multiple endpoints in clinical trials with adaptive interim analyses
    Kieser, M
    Bauer, P
    Lehmacher, W
    BIOMETRICAL JOURNAL, 1999, 41 (03) : 261 - 277
  • [6] Analyzing multiple endpoints in clinical trials of pain treatments: IMMPACT recommendations
    Turk, Dennis C.
    Dworkin, Robert H.
    McDermott, Michael P.
    Bellamy, Nicholas
    Burke, Laurie B.
    Chandler, Julie M.
    Cleeland, Charles S.
    Cowan, Penney
    Dimitrova, Rozalina
    Farrar, John T.
    Hertz, Sharon
    Heyse, Joseph F.
    Iyengar, Smriti.
    Jadad, Alejandro R.
    Jay, Gary W.
    Jermano, John A.
    Katz, Nathaniel P.
    Manning, Donald C.
    Martin, Susan
    Max, Mitchell B.
    McGrath, Patrick
    McQuay, Henry J.
    Quessy, Steve
    Rappaport, Bob A.
    Revicki, Dennis A.
    Rothman, Margaret
    Stauffer, Joseph W.
    Svensson, Ola
    White, Richard E.
    Witter, James
    PAIN, 2008, 139 (03) : 485 - 493
  • [7] Statistical planning in confirmatory clinical trials with multiple treatment groups, multiple visits, and multiple endpoints
    Sun, Hengrui
    Snyder, Ellen
    Koch, Gary G.
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2018, 28 (01) : 189 - 211
  • [8] A flexible fixed-sequence testing method for hierarchically ordered correlated multiple endpoints in clinical trials
    Huque, Mohammad F.
    Alosh, Mohamed
    JOURNAL OF STATISTICAL PLANNING AND INFERENCE, 2008, 138 (02) : 321 - 335
  • [9] Optimal planning of phase II/III programs for clinical trials with multiple endpoints
    Kieser, Meinhard
    Kirchner, Marietta
    Doelger, Eva
    Goette, Heiko
    PHARMACEUTICAL STATISTICS, 2018, 17 (05) : 437 - 457
  • [10] The impact of allocation bias on test decisions in clinical trials with multiple endpoints using multiple testing strategies
    Schoenen, Stefanie
    Heussen, Nicole
    Verbeeck, Johan
    Hilgers, Ralf-Dieter
    BMC MEDICAL RESEARCH METHODOLOGY, 2024, 24 (01)
1234